Nasdaq: IMMX
Immix Biopharma insiders
The officers, directors and 10% owners of Immix Biopharma, Inc. who hold the most stock, valued at the live IMMX price.
$7.04
IMMX today −$70K (−0.98%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their IMMX stock
- $83.1M
- Market value
- $590M
- Held by ranked insiders
- 14.1%
Insiders by value of IMMX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jason Hsu | Director | 4,865,163 | $34.3M | 5.80% | 3397th |
| 2 | Yekaterina Chudnovsky | Director | 3,247,326 | $22.9M | 3.87% | 3358th |
| 3 | Ilya Rachman | CEO and Chairman | 1,141,683 | $8.0M | 1.36% | 10346th |
| 4 | Vladimir Torchilin | Scientific Co-Founder | 905,200 | $6.4M | 1.08% | 12227th |
| 5 | Sean Senn | Insider | 899,800 | $6.3M | 1.07% | 12286th |
| 6 | Gabriel Morris | CFO | 718,273 | $5.1M | 0.86% | 14345th |
| 7 | Jane Buchan | Director | 28,705 | $202K | <0.1% | 7400th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Immix Biopharma; see each profile for the filing.